Clinical Trial Update: Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy of apixaban in patients with malignancy-associated deep vein thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Malignancy

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Beni-Suef University | Conditions: Deep Vein Thrombosis, Malignancy | Phase 3 | Status: UNKNOWN